AHNS Series: Do you know your guidelines? Principles of Treatment for Locally Advanced or Unresectable Head and Neck Squamous Cell Carcinoma

per Fulcher, Cory D., Haigentz, Missak, Ow, Thomas J.
Publicat a Head Neck (2017)

Palbociclib renders human papilloma virus-negative head and neck squamous cell carcinoma vulnerable to the senolytic agent navitoclax

per Gadsden, Nicholas J., Fulcher, Cory D., Li, Daniel, Shrivastava, Nitisha, Thomas, Carlos, Segall, Jeffrey E., Prystowsky, Michael B., Schlecht, Nicolas F., Gavathiotis, Evripidis, Ow, Thomas J.
Publicat a Mol Cancer Res (2021)

Apoptosis Signaling Molecules as Treatment Targets in Head and Neck Squamous Cell Carcinoma

per Ow, Thomas J., Thomas, Carlos, Fulcher, Cory D., Chen, Jianhong, López, Andrea, Reyna, Denis E., Prystowsky, Michael B., Smith, Richard V., Schiff, Bradley A., Rosenblatt, Gregory, Belbin, Thomas J., Harris, Thomas M., Childs, Geoffrey C., Kawachi, Nicole, Schlecht, Nicolas F., Gavathiotis, Evripidis
Publicat a Laryngoscope (2020)

Reply to “Regarding: Apoptosis Signaling Molecules as Treatment Targets in Head and Neck Squamous Carcinoma”

per Ow, Thomas J., Thomas, Carlos, Fulcher, Cory D., Chen, Jianhong, López, Andrea, Reyna, Denis E., Prystowsky, Michael B., Smith, Richard V., Schiff, Bradley A., Rosenblatt, Gregory, Belbin, Thomas J., Harris, Thomas M., Childs, Geoffrey C., Kawachi, Nicole, Schlecht, Nicolas F., Gavathiotis, Evripidis
Publicat a Laryngoscope (2020)

Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1

per Ow, Thomas J., Fulcher, Cory D., Thomas, Carlos, Broin, Pilib Ó, López, Andrea, Reyna, Denis E., Smith, Richard V., Sarta, Catherine, Prystowsky, Michael B., Schlecht, Nicolas F., Schiff, Bradley A., Rosenblatt, Gregory, Belbin, Thomas J., Harris, Thomas M., Childs, Geoffrey C., Kawachi, Nicole, Guha, Chandan, Gavathiotis, Evripidis
Publicat a Oncotarget (2019)